导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.17% | 335/1050 |
| 近一周 | -1.07% | 475/1104 |
| 近一月 | -2.05% | 366/1103 |
| 近一季 | -4.22% | 432/1092 |
| 近半年 | 6.02% | 318/1070 |
| 近一年 | 20.47% | 251/1018 |
| 近两年 | 84.86% | 278/926 |
| 近三年 | 63.47% | 196/834 |
| 成立以来 | 250.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.06% 720/1070 |
23.93% 353/1101 |
- - |
- - |
| 2025 | 38.43% 343/1065 |
3.27% 528/1014 |
1.80% 523/1038 |
27.97% 392/1050 |
2.89% 249/1065 |
| 2024 | 14.40% 190/1011 |
4.12% 132/960 |
-0.63% 347/983 |
13.53% 344/991 |
-2.60% 497/1011 |
| 2023 | -6.97% 251/952 |
7.82% 175/880 |
-3.83% 439/895 |
-5.44% 343/915 |
-5.11% 519/952 |
| 2022 | 0.35% 16/867 |
-9.80% 98/773 |
5.99% 458/806 |
-4.60% 58/845 |
10.03% 77/867 |
| 2021 | 30.55% 69/740 |
8.08% 17/580 |
3.21% 498/659 |
5.81% 112/704 |
10.60% 69/740 |
| 2020 | 34.10% 332/554 |
-5.49% 305/419 |
11.30% 390/466 |
17.91% 81/517 |
8.12% 389/554 |
| 2019 | 36.14% 254/410 |
22.12% 858/1146 |
-1.02% 443/1228 |
0.86% 313/390 |
11.67% 117/410 |
| 2018 | -13.63% 19/349 |
- - |
-4.10% 166/990 |
-2.97% 369/1000 |
-7.85% 143/1080 |
| 2017 | 40.96% 14/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.24% 63/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 诺安低碳经济股票A VS. 东吴新产业精选股票A(580008) |